Dabigatran etexilate is a direct thrombin inhibitor used as an anticoagulant to prevent blood clots in patients with conditions such as atrial fibrillation. This category provides essential reference standards,… Read more
Dabigatran etexilate is a direct thrombin inhibitor used as an anticoagulant to prevent blood clots in patients with conditions such as atrial fibrillation. This category provides essential reference standards, including the active pharmaceutical ingredient and its mesylate salt form, to support the rigorous demands of pharmaceutical analysis. Laboratories utilize these high-quality compounds for impurity profiling and method validation, ensuring compliance with regulatory standards throughout the drug development lifecycle. The collection also features identified related substances, such as impurities A, C, E, and F, alongside stable isotope labelled compounds. By incorporating these materials into quality control protocols, researchers can accurately quantify levels of degradation products and metabolites, facilitating the assessment of drug stability and the precision of analytical testing procedures.